# OnCo record aadi-bioscience (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aadi-bioscience/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aadi-bioscience" ;
  schema:name "Aadi Bioscience"@en ;
  schema:alternateName "Whitehawk Therapeutics"@en, "Aadi Bioscience, Inc."@en, "NASDAQ:AADI"@en ;
  schema:description "Aadi Bioscience won approval for Fyarro, the albumin-bound sirolimus that treats the rare sarcoma PEComa, then sold it and renamed itself Whitehawk Therapeutics to develop antibody-drug conjugates."@en ;
  schema:url <https://onco.cc/companies/aadi-bioscience/>, <https://www.aadibio.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.aadibio.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/sirolimus-albumin-bound/> .